(2S,5R)-5-羟基-2-(羟基甲基)-2,5,7-三甲基螺[1H-茚-6,1'-环丙烷]-4-酮 | 112953-13-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: (2S,5R)-5-羟基-2-(羟基甲基)-2,5,7-三甲基螺[1H-茚-6,1'-环丙烷]-4-酮
• 英文名称: 6-Deoxyilludin S
• 英文别名: (2S,5R)-5-hydroxy-2-(hydroxymethyl)-2,5,7-trimethylspiro[1H-indene-6,1'-cyclopropane]-4-one
• CAS: 112953-13-6
• 化学式: C₁₅H₂₀O₃
• 分子量: 248.32
• InChiKey: IEHHZEZPEUURRA-KBPBESRZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• AFFINITY MEDICANT CONJUGATE
  申请人：AF CHEMICALS, LLC

  公开号：US20150290152A1

  公开（公告）日：2015-10-15

  In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The medicant moiety can be a toxin including an acylfulvene or a drug moiety. The affinity moiety can be an antibody, a binding protein, a steroid, a lipid, a growth factor, a protein, a peptide or non peptidic. The affinity moiety can be covalently bound to the medicant via a linker. Novel linkers that can be directed to cysteine, arginine or lysine residues based on solution pH allow greater flexibility in preserving and/or generating specific epitopes in the AMC.
• US9381178B2
  申请人：——

  公开号：US9381178B2

  公开（公告）日：2016-07-05